Related Experiment Video
Updated: May 31, 2026
07:10
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Statins and outcome after hospitalization for COPD exacerbation: a prospective study
Konstantinos Bartziokas1, Andriana I Papaioannou, Markos Minas
1Respiratory Medicine Department, University of Thessaly Medical School, Larissa, Greece.
Pulmonary Pharmacology & Therapeutics
|July 7, 2011
Summary
Statins may reduce exacerbations in COPD patients. This prospective study found statin use associated with fewer COPD exacerbations and improved quality of life, supporting their potential role in managing COPD.
Area of Science:
- Pulmonary Medicine
- Pharmacology
- Clinical Research
Background:
- Retrospective studies suggest statins reduce mortality and hospitalizations in COPD.
- Prospective data on statin use in COPD exacerbations were previously lacking.
Purpose of the Study:
- To prospectively evaluate the impact of statins on outcomes in patients hospitalized for COPD exacerbations (ECOPD).
Main Methods:
- Prospective follow-up of 245 patients hospitalized for ECOPD over one year.
- Cox regression analysis adjusted for covariates to assess statin effects on outcomes.
- Health-related quality of life (HRQoL) assessed using Saint George's Respiratory Questionnaire.
Main Results:
- No significant effect of statins on 30-day or 1-year mortality.
- Statin users had fewer total ECOPD over one year (2.1 vs. 2.8 per patient, p=0.037).
- Statin use was associated with a reduced risk of ECOPD (HR: 0.656) and severe ECOPD (HR: 0.608), and improved HRQoL.
Conclusions:
- Statin use in hospitalized ECOPD patients is linked to a lower risk of subsequent exacerbations and improved HRQoL.
- These findings suggest a potential beneficial role for statins in COPD management.
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation